轩竹生物-B(02575)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02575 轩竹生物-B

未开盘 12-05 16:09:06

64.750

+1.750

+2.78%

最高66.300	最低62.900	成交量34.56万
今开62.900	昨收63.000	日振幅5.40%
总市值335.37亿	流通市值104.05亿	总股本5.18亿
成交额2,257万	换手率0.22%	流通股本1.61亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02575","market":"HK","secType":"STK","nameCN":"轩竹生物-B","latestPrice":64.75,"timestamp":1764922146468,"preClose":63,"halted":0,"volume":345556,"delay":0,"floatShares":160701996,"shares":517947790,"eps":-1.3598620579039966,"marketStatus":"未开盘","change":1.75,"latestTime":"12-05 16:09:06","open":62.9,"high":66.3,"low":62.9,"amount":22566390,"amplitude":0.053968,"askPrice":65.7,"askSize":500,"bidPrice":64.75,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":-1.3596957679402744,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":0,"adr":0,"listingDate":1760457600000,"exchange":"SEHK","adjPreClose":63,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0.9061125809452926,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02575","defaultTab":"news","newsList":[{"id":"1133543268","title":"轩竹生物科技（02575）更新11月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1133543268","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133543268?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:36","pubTimestamp":1764837367,"startTime":"0","endTime":"0","summary":"轩竹生物科技股份有限公司于2025年12月4日发布截至2025年11月30日的股份变动月报表。根据公告，报告期内公司股本结构未发生变化，已发行H股数量保持在160,701,996股，未上市普通股数量维持357,245,794股，两项合计517,947,790股。公司本月无新增发行、购回、注销或库藏股活动。公司声明其遵守香港联交所《上市规则》的相关规定，本次月报由联席公司秘书何成明签署。公司同时强调将持续按要求披露后续股份变动情况，以维护投资者对公司资本状况的了解。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"gpt_icon":0},{"id":"2586308440","title":"轩竹生物-B盘中异动 股价大涨5.72%报67.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586308440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586308440?lang=zh_cn&edition=full","pubTime":"2025-11-25 09:32","pubTimestamp":1764034332,"startTime":"0","endTime":"0","summary":"2025年11月25日早盘09时32分，轩竹生物-B股票出现异动，股价快速拉升5.72%。截至发稿，该股报67.500港元/股，成交量1.2万股，换手率0.01%，振幅5.56%。资金方面，该股资金流入45.6975万港元，流出6.665万港元。轩竹生物-B股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，银诺医药-B、康方生物、轩竹生物-B涨幅较大，振幅较大的相关个股有华康生物医学、银诺医药-B、轩竹生物-B，振幅分别为11.27%、8.69%、4.23%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125093212a4b82bf0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125093212a4b82bf0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":0},{"id":"2585323129","title":"轩竹生物-B11月21日主力净流出242.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2585323129","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585323129?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:15","pubTimestamp":1763712937,"startTime":"0","endTime":"0","summary":"11月21日, 轩竹生物-B股价跌0.63%，报收63.20元，成交金额2171.3万元，换手率0.21%，振幅1.42%，量比0.97。轩竹生物-B今日主力资金净流出242.6万元，上一交易日主力净流入11.5万元。该股近5个交易日下跌1.80%，主力资金累计净流出166.5万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出270.8万元，其中净流出天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121161800a7088a3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121161800a7088a3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":0},{"id":"2584385959","title":"四环医药(00460.HK)：轩竹生物尚未就H股于联交所主板上市及买卖向联交所提出申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2584385959","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584385959?lang=zh_cn&edition=full","pubTime":"2025-11-18 23:07","pubTimestamp":1763478425,"startTime":"0","endTime":"0","summary":"格隆汇11月18日丨四环医药(00460.HK)公告，内容有关经轩竹生物董事会考虑及批准实施H股全流通的建议，轩竹生物已于2025年11月17日向中国证券监督管理委员会提交备案申请，以按一对一基准将六名股东合共357,245,794股轩竹生物未上市股份转换为H股(占轩竹生物于2025年11月14日已发行股份总数约68.9733%)。\r\n\r\n　　于本公告日期，轩竹生物尚未就该等H股于联交所主板上市及买卖向联交所提出申请，且有关执行计划详情尚未落实。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251118/31806223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02575","BK1593","BK1600","00460","BK1515","BK1191"],"gpt_icon":0},{"id":"2584295244","title":"轩竹生物-B11月18日主力净流出403.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2584295244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584295244?lang=zh_cn&edition=full","pubTime":"2025-11-18 16:15","pubTimestamp":1763453738,"startTime":"0","endTime":"0","summary":"11月18日, 轩竹生物-B股价跌0.63%，报收63.20元，成交金额2198.7万元，换手率0.22%，振幅1.97%，量比1.02。轩竹生物-B今日主力资金净流出403.6万元，上一交易日主力净流入471.1万元。该股近5个交易日下跌2.17%，主力资金累计净流出640.2万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入3910.5万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118161847a4a9b1e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118161847a4a9b1e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":0},{"id":"2584648040","title":"轩竹生物-B(02575)就建议实施H股全流通向中国证监会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2584648040","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584648040?lang=zh_cn&edition=full","pubTime":"2025-11-17 16:32","pubTimestamp":1763368334,"startTime":"0","endTime":"0","summary":"智通财经APP讯，轩竹生物-B(02575)公布，于 2025年 11月 17日，公司已向中国证监会提交备案申请，内容有关建议实施H股全流通，以按一对一基准将合共357,245,794股未上市股份转换为H股。待完成所有备案规定(包括向中国证监会备案)并获得所有相关批准(包括联交所批准转换及上市)并遵守所有适用法律、法规及规则后，357,245,794股未上市股份将转换为357,245,794股H股，并将于联交所上市及买卖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02575"],"gpt_icon":0},{"id":"2583575835","title":"轩竹生物-B(02575)建议实施H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2583575835","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583575835?lang=zh_cn&edition=full","pubTime":"2025-11-14 16:32","pubTimestamp":1763109131,"startTime":"0","endTime":"0","summary":"智通财经APP讯，轩竹生物-B(02575)公布，于 2025年11月14日，董事会经考虑及批准实施H股全流通的建议，即将公司六名股东持有的357,245,794股公司未上市股份转换为公司H股(占公司于本公告日期已发行股份总数约68.9733%)。待取得所有相关批准(包括向中国证监会存档)并遵守所有适用法律、法规及规则后，357,245,794股未上市股份将转换为H股，而公司亦将向联交所申请批准该等H股于联交所主板上市及买卖。于本公告日期，公司尚未向中国证监会申请H股全流通。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369299.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02575"],"gpt_icon":0},{"id":"2583509577","title":"轩竹生物-B11月14日遭主力抛售32.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583509577","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583509577?lang=zh_cn&edition=full","pubTime":"2025-11-14 16:15","pubTimestamp":1763108122,"startTime":"0","endTime":"0","summary":"11月14日, 轩竹生物-B股价跌0.23%，报收63.95元，成交金额2318.9万元，换手率0.23%，振幅2.81%，量比0.92。轩竹生物-B今日主力资金净流出32.6万元，连续6日净流出，上一交易日主力净流出332.5万元。该股近5个交易日下跌2.39%，主力资金累计净流出1402.8万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入4820.8万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114161647a4a10c35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114161647a4a10c35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":0},{"id":"2582352318","title":"轩竹生物-B11月11日遭主力抛售556.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582352318","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582352318?lang=zh_cn&edition=full","pubTime":"2025-11-11 16:15","pubTimestamp":1762848954,"startTime":"0","endTime":"0","summary":"11月11日, 轩竹生物-B股价跌2.34%，报收64.65元，成交金额2105.2万元，换手率0.20%，振幅3.55%，量比0.79。轩竹生物-B今日主力资金净流出556.8万元，连续3日净流出，上一交易日主力净流出138.3万元。该股近5个交易日下跌0.92%，主力资金累计净流出500.1万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入6352.1万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111116214494fd37ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111116214494fd37ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":0},{"id":"2582335618","title":"荣誉 | 轩竹生物荣膺中国证券报“成长价值金牛奖”","url":"https://stock-news.laohu8.com/highlight/detail?id=2582335618","media":"轩竹生物","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582335618?lang=zh_cn&edition=full","pubTime":"2025-11-10 16:39","pubTimestamp":1762763983,"startTime":"0","endTime":"0","summary":"11月8日，由中国证券报主办、新华社新闻信息中心承办的“2025厦门产业发展大会暨金圆集团杯·上市公司（港股）金牛奖颁奖典礼”于厦门成功举行。本次大会上，轩竹生物科技股份有限公司凭借在生物医药领域突出的创新研发能力、强劲的成长潜力与广阔的发展前景，从一众入围企业中脱颖而出，荣膺“成长价值金牛奖”。此次荣获“成长价值金牛奖”，正是对公司创新研发实力、全链条开发能力与高质量成长潜力的最佳印证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110164155a6ef0747&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251110164155a6ef0747&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":0},{"id":"2581097115","title":"轩竹生物-B11月06日主力净流入203.0万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2581097115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581097115?lang=zh_cn&edition=full","pubTime":"2025-11-06 16:15","pubTimestamp":1762416947,"startTime":"0","endTime":"0","summary":"11月06日, 轩竹生物-B股价涨6.34%，报收69.65元，成交金额4123.2万元，换手率0.38%，振幅9.92%，量比1.69。轩竹生物-B今日主力资金净流入203.0万元，上一交易日主力净流出0万元。该股近5个交易日上涨10.56%，主力资金累计净流入889.2万元；近20日主力资金累计净流入7055.3万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110616203394f2d684&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110616203394f2d684&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":0},{"id":"2581056710","title":"港股异动 | 轩竹生物-B(02575)尾盘涨超9%创上市新高 NG-350A此前获授美国FDA快速通道资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2581056710","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581056710?lang=zh_cn&edition=full","pubTime":"2025-11-06 15:52","pubTimestamp":1762415537,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，轩竹生物-B尾盘涨超9%，高见71.6港元创上市新高。消息面上，轩竹生物上月底宣布，集团从临床阶段肿瘤公司Akamis授权引进的产品NG-350A获得美国食品药品监督管理局授予快速通道资格，用于治疗错配修复功能完整的局部晚期直肠癌。国家医保局此前公布的通过初步形式审查的名单显示，轩竹生物的吡洛西利片已成功入围，对于吡洛西利片而言，能否最终纳入国家医保目录同样至关重要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NG","02575","BK4017"],"gpt_icon":0},{"id":"2580291016","title":"轩竹生物-B11月03日获主力加仓285.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580291016","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580291016?lang=zh_cn&edition=full","pubTime":"2025-11-03 16:15","pubTimestamp":1762157738,"startTime":"0","endTime":"0","summary":"11月03日, 轩竹生物-B股价涨4.32%，报收66.35元，成交金额2200.1万元，换手率0.21%，振幅9.43%，量比0.42。轩竹生物-B今日主力资金净流入285.2万元，连续4日净流入，上一交易日主力净流入401.0万元。该股近5个交易日上涨11.58%，主力资金累计净流入979.0万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入6852.2万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103161851a6dd5f6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103161851a6dd5f6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":0},{"id":"2580294839","title":"轩竹生物－Ｂ股价大涨5.03% 吡洛西利治疗乳腺癌临床III期研究数据于ESMO公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2580294839","media":"港美通","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580294839?lang=zh_cn&edition=full","pubTime":"2025-11-03 15:11","pubTimestamp":1762153911,"startTime":"0","endTime":"0","summary":"11月3日14:53，轩竹生物－Ｂ(02575)股价大幅上涨5.03%。该股报66.800港元，最高报66.800港元，最低报62.000港元，成交量19.27万股，成交额1237.43万港元。消息面上，轩竹生物近日发布公告称，公司在2025年欧洲肿瘤内科学会（ESMO）上以壁报的形式展示了吡洛西利联合来曲唑或阿那曲唑在HR+/HER2-（激素受体阳性、人表皮生长因子受体2阴性）晚期乳腺癌一线治疗的临床Ⅲ期（BRIGHT-3）的期中分析结果。据悉，轩竹生物科技股份有限公司是一家中国生物制药公司，公司有超过十种药物资产在积极开发中，涵盖消化系统疾病、肿瘤和NASH。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103152010a6dd39e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103152010a6dd39e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":0},{"id":"2580490217","title":"轩竹生物-B10月31日获主力加仓401.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580490217","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580490217?lang=zh_cn&edition=full","pubTime":"2025-10-31 16:15","pubTimestamp":1761898554,"startTime":"0","endTime":"0","summary":"10月31日, 轩竹生物-B股价涨0.95%，报收63.60元，成交金额3214.3万元，换手率0.31%，振幅8.25%，量比0.44。轩竹生物-B今日主力资金净流入401.0万元，连续3日净流入，上一交易日主力净流入216.8万元。该股近5个交易日上涨6.39%，主力资金累计净流入818.4万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入6567.0万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116223794e71a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025103116223794e71a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":0},{"id":"2578393801","title":"轩竹生物-B(02575)：NG-350A获授美国FDA快速通道资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2578393801","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578393801?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:35","pubTimestamp":1761640501,"startTime":"0","endTime":"0","summary":"智通财经APP讯，轩竹生物-B(02575)发布公告，集团从临床阶段肿瘤公司AkamisBioLtd.(Akamis)授权引进的产品NG-350A获得美国食品药品监督管理局(FDA)授予快速通道资格(FastTrackdesignation)，用于治疗错配修复功能完整(pMMR)的局部晚期直肠癌(LARC)。集团拥有NG-350A产品的大中华区开发、生产与商业化的独家权利。FDA快速通道资格认定是一种加速开发和审批潜在药物的方法。被授予快速通道资格认定的药物旨在治疗严重疾病并解决未满足的医疗需求，其可能是针对特定疾病的首个疗法，或与现有疗法相比更具显着临床优势，或提高现有疗法的安全性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1361225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NG","02575","BK4017"],"gpt_icon":0},{"id":"1126538132","title":"轩竹生物-B再飙逾8%，股价创上市以来新高！该股上市至今累计上涨逾450%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126538132","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126538132?lang=zh_cn&edition=full","pubTime":"2025-10-27 13:17","pubTimestamp":1761542266,"startTime":"0","endTime":"0","summary":"次新股$轩竹生物-B(02575)$再飙逾8%，股价站上65港元/股，创上市以来新高！该股上市至今累计上涨逾450%。","market":"hk","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4b523e98237f91adae828bb001360c45","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575"],"gpt_icon":0},{"id":"2578304660","title":"轩竹生物-B(02575)涨5.2% 上市两周股价翻倍 吡洛西利一线治疗临床III期展现出良好的疗效性","url":"https://stock-news.laohu8.com/highlight/detail?id=2578304660","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578304660?lang=zh_cn&edition=full","pubTime":"2025-10-27 10:47","pubTimestamp":1761533275,"startTime":"0","endTime":"0","summary":"金吾财讯 | 轩竹生物-B(02575)再起升势，截至发稿，涨5.2%，报62.7港元，成交额2055万港元。需要注意的是该股于10月16日盘中最低点23.82港元至今日涨幅超1.6倍。消息面上，日前，2025年欧洲肿瘤内科学会(ESMO)年会正式召开。作为全球最具学术影响力的肿瘤学盛会之一，ESMO向来是创新药企业披露核心品种重磅临床数据的重要平台，各大药企借此不仅能提升自身知名度与行业影响力，更可拓展合作机遇。港股上市仅两周的轩竹生物，此次便在ESMO大会披露吡洛西利一线治疗临床III期(BRIGHT-3)研究数据，展现出良好的疗效性和安全优势。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OWU0MGRiNDM1NDA5NTM4MzU5OQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1968487","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4134","02575","III"],"gpt_icon":0},{"id":"1110501310","title":"一周港股牛熊榜 | 周内飙升75%！次新股轩竹生物上市累升逾400%；老铺黄金、泡泡玛特周跌超16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110501310","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110501310?lang=zh_cn&edition=full","pubTime":"2025-10-24 17:34","pubTimestamp":1761298484,"startTime":"0","endTime":"0","summary":"10月15日，优必选宣布与某知名上市汽车科技公司正式签署人形机器人采购合同，订单金额超3200万元。值得注意的是，10月17日，老铺黄金发布预告，公司将于10月26日进行产品价格调整。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"一周港股牛熊榜 | 周内飙升75%！次新股轩竹生物上市累升逾400%；老铺黄金、泡泡玛特周跌超16%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","02575","09992","00412","03677","01729","01635","06181","01651","09880"],"gpt_icon":1},{"id":"2577593543","title":"轩竹生物-B10月24日主力净流入124.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2577593543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577593543?lang=zh_cn&edition=full","pubTime":"2025-10-24 16:15","pubTimestamp":1761293719,"startTime":"0","endTime":"0","summary":"10月24日, 轩竹生物-B股价涨0.17%，报收59.60元，成交金额4627.4万元，换手率0.49%，振幅12.69%，量比0.25。轩竹生物-B今日主力资金净流入124.5万元，上一交易日主力净流出286.4万元。该股近5个交易日上涨75.81%，主力资金累计净流入4016.8万元；近20日主力资金累计净流入5873.2万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102416160597400a81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102416160597400a81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02575"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xuanzhubio.com","stockEarnings":[{"period":"1week","weight":0.0278},{"period":"1month","weight":-0.0115},{"period":"3month","weight":4.5819},{"period":"ytd","weight":4.5819}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"轩竹生物科技股份有限公司是一家根植于中国、具有全球化视野的创新型制药企业,聚焦于消化、肿瘤及非酒精性脂肪性肝炎等重大疾病领域,致力于持续开发并商业化具有核心自主知识产权的1类新药,解决临床上未被满足的治疗需求。公司是一家根植于中国、具有全球化视野的创新型制药企业。","exchange":"SEHK","name":"轩竹生物-B","nameEN":"XUANZHUBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"轩竹生物-B(02575)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供轩竹生物-B(02575)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"轩竹生物-B,02575,轩竹生物-B股票,轩竹生物-B股票老虎,轩竹生物-B股票老虎国际,轩竹生物-B行情,轩竹生物-B股票行情,轩竹生物-B股价,轩竹生物-B股市,轩竹生物-B股票价格,轩竹生物-B股票交易,轩竹生物-B股票购买,轩竹生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"轩竹生物-B(02575)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供轩竹生物-B(02575)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}